Pharmaceutical Grade 1009119-65-6 Daclatasvir Bakeng sa Phekolo ea Hepatitis C
Sehlahisoalebitso | Daclatasvir2HCl |
Litlhaloso tse tšoanang | N,N'-[[1,1'-Biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1 -methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride;BMS 790052 |
Nomoro ea CAS. | 1009119-65-6 |
Ponahalo | Phofo e tšoeu ho isa ho e mosehla |
Foromo ea limolek'hule | C40H50N8O6.2(HCl) |
Boima ba Molek'hule | 811.81 |
Tšebeliso | Pharmaceutical Grade for Research purpose |
Ho paka | Joalo ka kopo ea hau |
Polokelo | Boloka ka lijaneng tse thata, tse sa keneleng khanya sebakeng se phodileng |
Daclatasvir2HCl Cas:1009119-65-6 | ||
Lintho | Standard | Liphetho |
Litšobotsi | Phofo e tšoeu ho isa ho e mosehla | Phofo e 'mala o mosehla |
Likahare tsa metsi | ≦1.0% | 0.25% |
Bohloeki | ≧99% | 99.7% |
Tšilafalo e le 'ngoe | ≦0.1% | 0.06% |
Masalla ha a tuka | ≦0.1% | E lumellana |
Qetello | E lumellana le litlhaloso tsa ka tlung. |
Lintlha tsa Khampani
√ Boiphihlelo bo felletseng ba Management layer ho balateli ba lifeme le litsebi tse nang le boiphihlelo; √ Boleng ke kamehla ho nahanela rona holimo, Strict QC tsamaiso; √ lilemo tse 11 tse nang le boiphihlelo sehlopheng sa thekiso ea thepa kantle ho naha; √ Lab e ikemetseng ya R&D; √ Lithupelo tse peli tsa nako e telele tsa GMP; √ Lisebelisoa tse ruileng tsa lifeme tse ngata tse sa sebetseng bakeng sa morero o hlophisitsoeng; √ Sehlopha se sebetsang se sebetsang hantle se nang le tsela e tsitsitseng.Ngola molaetsa wa hao mona mme o re romele wona